Cargando…

Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial

BACKGROUND: Gastroesophageal reflux disease (GERD) is a major cause of chronic cough. GERD-induced chronic cough is difficult to diagnose because some patients do not complain of any gastrointestinal (GI) reflux symptoms. Although chronic cough due to GERD is highly prevalent, no effective treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhang, Yeon Hee, Kim, Kwan-Il, Kim, Jaehyo, Ahn, Junmo, Jung, Hwan-Su, Yang, Changsop, Ko, Seok-Jae, Bu, Youngmin, Park, Jae-Woo, Park, Kyoung Sun, Jung, Hee-Jae, Lee, Jun-Hwan, Lee, Beom-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990619/
https://www.ncbi.nlm.nih.gov/pubmed/31996267
http://dx.doi.org/10.1186/s13063-019-4030-z
_version_ 1783492541740482560
author Bhang, Yeon Hee
Kim, Kwan-Il
Kim, Jaehyo
Ahn, Junmo
Jung, Hwan-Su
Yang, Changsop
Ko, Seok-Jae
Bu, Youngmin
Park, Jae-Woo
Park, Kyoung Sun
Jung, Hee-Jae
Lee, Jun-Hwan
Lee, Beom-Joon
author_facet Bhang, Yeon Hee
Kim, Kwan-Il
Kim, Jaehyo
Ahn, Junmo
Jung, Hwan-Su
Yang, Changsop
Ko, Seok-Jae
Bu, Youngmin
Park, Jae-Woo
Park, Kyoung Sun
Jung, Hee-Jae
Lee, Jun-Hwan
Lee, Beom-Joon
author_sort Bhang, Yeon Hee
collection PubMed
description BACKGROUND: Gastroesophageal reflux disease (GERD) is a major cause of chronic cough. GERD-induced chronic cough is difficult to diagnose because some patients do not complain of any gastrointestinal (GI) reflux symptoms. Although chronic cough due to GERD is highly prevalent, no effective treatment is currently available, especially for GERD-related cough without GI symptoms. Because the herbal medicines Ojeok-san and Saengmaek-san can effectively treat GERD and cough, we aim to evaluate the efficacy and safety of a combination of these components for relieving chronic cough due to GERD. METHODS/DESIGN: This is a study protocol of a randomized, double-blind, placebo-controlled, single-center pilot trial. After a 1-week run-in period, a total of 30 patients with GERD-induced chronic cough will be randomly allocated to an intervention group (n = 15) or a placebo group (n = 15). Participants will receive 5.76 g of Ojeok-san plus Saengmaek-san or a placebo three times per day for 6 weeks. The primary outcome measures, which are the frequency and severity of cough, will be recorded using a cough diary. The secondary outcome measures will include a cough visual analogue scale, the Leicester Cough Questionnaire (Korean version), the Gastrointestinal Symptom Rating Scale, the Hull Airway Reflux (hypersensitivity) Questionnaire, the Pattern Identification for Chronic Cough Questionnaire, the Pattern Identification for Gastroesophageal Reflux Disease, and safety testing. Adverse events will also be reported. DISCUSSION: This will be the first clinical trial to explore the use of herbal medicines for GERD-related chronic cough, including patients without GI reflux symptoms. This study will provide useful evidence regarding the efficacy and safety of Ojeok-san plus Saengmaek-san treatment. In addition, this trial will offer a scientific basis for the combination of herbal medicines. This study will also provide important data for conducting a larger-scale clinical trial on GERD-induced chronic cough. TRIAL REGISTRATION: This trial has been registered with Clinical Research Information Service (CRIS) of South Korea (http://cris.nih.go.kr; registration number KCT0003115). Registered August 28, 2018.
format Online
Article
Text
id pubmed-6990619
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69906192020-02-04 Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial Bhang, Yeon Hee Kim, Kwan-Il Kim, Jaehyo Ahn, Junmo Jung, Hwan-Su Yang, Changsop Ko, Seok-Jae Bu, Youngmin Park, Jae-Woo Park, Kyoung Sun Jung, Hee-Jae Lee, Jun-Hwan Lee, Beom-Joon Trials Study Protocol BACKGROUND: Gastroesophageal reflux disease (GERD) is a major cause of chronic cough. GERD-induced chronic cough is difficult to diagnose because some patients do not complain of any gastrointestinal (GI) reflux symptoms. Although chronic cough due to GERD is highly prevalent, no effective treatment is currently available, especially for GERD-related cough without GI symptoms. Because the herbal medicines Ojeok-san and Saengmaek-san can effectively treat GERD and cough, we aim to evaluate the efficacy and safety of a combination of these components for relieving chronic cough due to GERD. METHODS/DESIGN: This is a study protocol of a randomized, double-blind, placebo-controlled, single-center pilot trial. After a 1-week run-in period, a total of 30 patients with GERD-induced chronic cough will be randomly allocated to an intervention group (n = 15) or a placebo group (n = 15). Participants will receive 5.76 g of Ojeok-san plus Saengmaek-san or a placebo three times per day for 6 weeks. The primary outcome measures, which are the frequency and severity of cough, will be recorded using a cough diary. The secondary outcome measures will include a cough visual analogue scale, the Leicester Cough Questionnaire (Korean version), the Gastrointestinal Symptom Rating Scale, the Hull Airway Reflux (hypersensitivity) Questionnaire, the Pattern Identification for Chronic Cough Questionnaire, the Pattern Identification for Gastroesophageal Reflux Disease, and safety testing. Adverse events will also be reported. DISCUSSION: This will be the first clinical trial to explore the use of herbal medicines for GERD-related chronic cough, including patients without GI reflux symptoms. This study will provide useful evidence regarding the efficacy and safety of Ojeok-san plus Saengmaek-san treatment. In addition, this trial will offer a scientific basis for the combination of herbal medicines. This study will also provide important data for conducting a larger-scale clinical trial on GERD-induced chronic cough. TRIAL REGISTRATION: This trial has been registered with Clinical Research Information Service (CRIS) of South Korea (http://cris.nih.go.kr; registration number KCT0003115). Registered August 28, 2018. BioMed Central 2020-01-29 /pmc/articles/PMC6990619/ /pubmed/31996267 http://dx.doi.org/10.1186/s13063-019-4030-z Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Bhang, Yeon Hee
Kim, Kwan-Il
Kim, Jaehyo
Ahn, Junmo
Jung, Hwan-Su
Yang, Changsop
Ko, Seok-Jae
Bu, Youngmin
Park, Jae-Woo
Park, Kyoung Sun
Jung, Hee-Jae
Lee, Jun-Hwan
Lee, Beom-Joon
Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial
title Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial
title_full Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial
title_fullStr Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial
title_full_unstemmed Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial
title_short Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial
title_sort efficacy and safety of ojeok-san plus saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990619/
https://www.ncbi.nlm.nih.gov/pubmed/31996267
http://dx.doi.org/10.1186/s13063-019-4030-z
work_keys_str_mv AT bhangyeonhee efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT kimkwanil efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT kimjaehyo efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT ahnjunmo efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT junghwansu efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT yangchangsop efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT koseokjae efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT buyoungmin efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT parkjaewoo efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT parkkyoungsun efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT jungheejae efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT leejunhwan efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial
AT leebeomjoon efficacyandsafetyofojeoksanplussaengmaeksanforgastroesophagealrefluxinducedchroniccoughprotocolforapilotrandomizeddoubleblindplacebocontrolledtrial